- Home
- SOL vs ATYR Comparison
SOL vs ATYR Comparison
Compare SOL & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- ATYR
- Stock Information
- Founded
- SOL 2005
- ATYR 2005
- Country
- SOL United States
- ATYR United States
- Employees
- SOL N/A
- ATYR N/A
- Industry
- SOL Semiconductors
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOL Technology
- ATYR Health Care
- Exchange
- SOL Nasdaq
- ATYR Nasdaq
- Market Cap
- SOL 94.9M
- ATYR 306.2M
- IPO Year
- SOL 2008
- ATYR 2015
- Fundamental
- Price
- SOL $1.91
- ATYR $5.25
- Analyst Decision
- SOL Strong Buy
- ATYR Strong Buy
- Analyst Count
- SOL 2
- ATYR 6
- Target Price
- SOL $4.50
- ATYR $20.20
- AVG Volume (30 Days)
- SOL 339.2K
- ATYR 3.5M
- Earning Date
- SOL 08-19-2025
- ATYR 08-12-2025
- Dividend Yield
- SOL N/A
- ATYR N/A
- EPS Growth
- SOL N/A
- ATYR N/A
- EPS
- SOL N/A
- ATYR N/A
- Revenue
- SOL $85,621,000.00
- ATYR N/A
- Revenue This Year
- SOL N/A
- ATYR $960.85
- Revenue Next Year
- SOL $45.37
- ATYR $1,283.47
- P/E Ratio
- SOL N/A
- ATYR N/A
- Revenue Growth
- SOL N/A
- ATYR N/A
- 52 Week Low
- SOL $1.04
- ATYR $1.48
- 52 Week High
- SOL $3.00
- ATYR $5.98
- Technical
- Relative Strength Index (RSI)
- SOL 62.80
- ATYR 57.23
- Support Level
- SOL $1.84
- ATYR $4.96
- Resistance Level
- SOL $1.91
- ATYR $5.47
- Average True Range (ATR)
- SOL 0.05
- ATYR 0.37
- MACD
- SOL -0.00
- ATYR -0.07
- Stochastic Oscillator
- SOL 95.65
- ATYR 61.11
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.